At the Vascular & Diabetic Foot Center at Baylor Scott & White The Heart Hospital – Plano, the focus is both to treat foot and ankle wounds and to prevent those wounds from occurring in the first place. As the only coordinated outpatient and inpatient program in North Texas with comprehensive care for the diabetic and vascular conditions affecting the foot, the Center takes a holistic approach to care.
With CT-derived fractional flow reserve (FFRct) analysis, Baylor Scott & White The Heart Hospital – Plano provides insight into the impact blockages have on blood flow in the heart – all without a trip to the cath lab. Especially for intermediate blockages, this advanced, noninvasive technology offers cardiologists critical information to determine if a blockage is not significant.
Baylor Scott & White The Heart Hospital – Plano is the only site in Dallas-Fort Worth currently enrolling participants in the SOLVE CRT trial. This innovative trial is evaluating a new cardiac resynchronization therapy (CRT) system that delivers pacing stimulation from inside the left ventricle – possibly eliminating the need for traditional left ventricular lead placement.
As the volume of ablation cases – and electrophysiology cases overall – has increased at Baylor Scott & White The Heart Hospital – Plano so has the hospital’s reputation as a leader for quality outcomes in the field. Since the hospital opened in 2007, ablation case volumes have gone from just over 300 a year to more than 1,000.
Coronary Artery Bypass Grafting (CABG) is performed using arteries and saphenous veins from patients to bypass blocked arteries in the heart. Over 400,000 are performed in the US annually. It is shown to be effective to prolong life and decrease angina. One disadvantage of the use of saphenous vein grafts in CABG procedures is the risk of decrease flow in the vein due to neointimal hyperplasia that could lead to graft failure. To address this issue, a new clinical trial is investigating the use of the VEST device – an external metal sleeve used around the vein graft – that could potentially improve the long-term patency of these common grafts.
